SEC Form 4 · accession 0001144204-18-053713
Edesa Biotech, Inc. · EDSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel E. Morse
Other
Period of report
Oct 12, 2018
Accepted (ET)
Oct 12, 2018 · 9:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001540159
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par valueF1 | Oct 12, 2018 | S | 7,047 | $1.314 | D | 20,741 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Issuer completed a 1-for-7 reverse share split of its common shares effective May 4, 2018. The amount stated reflects the post-split adjustment. Fractional shares resulting from the reverse share split were rounded to the nearest whole share.